Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Pediatr Blood Cancer. 2023 Sep 14;70(12):e30672. doi: 10.1002/pbc.30672

TABLE 2.

≥ Grade 3 toxicities observed in all (N=12) evaluable patients

# of Patients in Cycle 1
By Maximum Grade
Grade 3 Grade 4
Hematologic Type Toxicity Type
Hematologic Anemia 8
Lymphocyte count decreased 1 8
Neutrophil count decreased 1 4
Platelet count decreased 5
White blood cell decreased 8
Non-Hematologic  
Anorexia 1
Febrile neutropenia 2 1
Fever 2
GGT increased* 1
Hypertension* 1
Hypertriglyceridemia 1
Hypokalemia 3 1
Hypophosphatemia 2
Hypoxia* 1
Nausea 1
Proteinuria* 1
Sepsis 3
Weight loss* 1
*

dose limiting toxicity